|
1
|
Rachner TD, Khosla S and Hofbauer LC:
Osteoporosis: Now and the future. Lancet. 377:1276–1287. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bliuc D, Nguyen ND, Milch VE, Nguyen TV,
Eisman JA and Center JR: Mortality risk associated with low-trauma
osteoporotic fracture and subsequent fracture in men and women.
JAMA. 301:513–521. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dueregger A, Heidegger I, Ofer P, Perktold
B, Ramoner R, Klocker H and Eder IE: The use of dietary supplements
to alleviate androgen deprivation therapy side effects during
prostate cancer treatment. Nutrients. 6:4491–4519. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tuck SP and Datta HK: Osteoporosis in the
aging male: Treatment options. Clin Interv Aging. 2:521–536. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khosla S: Update in male osteoporosis. J
Clin Endocrinol Metab. 95:3–10. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang ZQ, Li JL, Sun YL, Yao M, Gao J, Yang
Z, Shi Q, Cui XJ and Wang YJ: Chinese herbal medicine for
osteoporosis: A systematic review of randomized controlled trails.
Evid. Based. Complement. Alternat. Med. 2013:3562602013.
|
|
7
|
Uebelhart D, Frey D, Frey-Rindova P,
Goerres G and Michel BA: Therapy of osteoporosis: Bisphosphonates,
SERM's, teriparatide and strontium. Z Rheumatol. 62:512–517.
2003.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Hong C, Zhou C, Xu D and Qu HB:
Screening antitumor compounds Psoralen and Isopsoralen from
Psoralea coryl folia L. Seeds. Evid Based Complement
Alternat Med. 2011:3630522011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu CR, Chang CL, Hsieh PY, Lin LW and
Ching H: Psoralen in isopsoralen, two coumarins of Psoraleae
Fructus, can alleviate scopolamine-induced amnesia in rats. Planta
Med. 73:275–278. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Z, Huang JH, Liu SF, Zhao YJ, Shen
ZY, Wang YJ and Bian Q: The osteoprotective effect of psoralen in
ovariectomy-induced osteoporotic rats via stimulating the
osteoblastic differentiation from bone mesenchymal stem cells.
Menopause. 19:1156–1164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang DZ, Yang F, Yang Z, Huang J, Shi Q,
Chen D and Wang YJ: Psoralen stimulates osteoblast differentiation
through activation of BMP signaling. Biochem Biophys Res Commun.
405:256–261. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsai MH, Huang GS, Hung YC, Bin L, Liao LT
and Lin LW: Psoralea corylifolia extract ameliorates
experimental osteoporosis in ovariectomized rats. Am J Chin Med.
35:669–680. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wong RW and Rabie AB: Effect of psoralen
on bone formation. J Orthop Res. 29:158–164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yuan X, Bi Y, Yan Z, Pu W, Li Y and Zhou
K: Psoralen and Isopsoralen ameliorate sex hormone
deficiency-induced osteoporosis in female and male mice. Biomed Res
Int. 2016:68694522016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu H, Zhang L, Liu D, Tang P and Song F:
Isolation and purification of psoralen and isopsoralen and their
efficacy and safety in the treatment of osteosarcoma in nude rats.
Afr Health Sci. 14:641–647. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ming L, Ge B, Chen K, Ma H and Zhai Y:
Effects of isopsoralen on bone marrow stromal stem cells
differentiate and proliferate in vitro. Zhongguo Zhong Yao Za Zhi.
36:2124–2128. 2011.(In Chinese). PubMed/NCBI
|
|
17
|
Neben CL and Merrill AE: Signaling
pathways in craniofacial development: Insights from rare skeletal
disorders. Curr Top Dev Biol. 115:493–542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alfaro MP, Pagni M, Vincent A, Atkinson J,
Hill MF, Cates J, Davidson JM, Rottman J, Lee E and Young PP: The
Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment,
granulation tissue formation and myocardial repair. Proc Natl Acad
Sci USA. 105:18366–18371. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lorenzon A, Calore M, Poloni G, De Windt
LJ, Braghetta P and Rampazzo A: Wnt/β-catenin pathway in
arrhythmogenic cardiomyopathy. Oncotarget. 8:60640–60655. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Burgers TA and Williams BO: Regulation of
Wnt/β-catenin signaling within and from osteocytes. Bone.
54:244–249. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duan P and Bonewald LF: The role of the
wnt/β-catenin signaling pathway in formation and maintenance of
bone and teeth. Int J Biochem Cell Biol. 77:23–29. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Skemiene KJ and Liobikas V: Borutaite.
Anthocyanins as substrates for mitochondrial complex I- protective
effect against heart ischemic injury. FEBS J. 282:963–971. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schurman L, Bagur A, Claus-Hermberg H,
Messina OD, Negri AL, Sánchez A, González C, Diehl M, Rey P, Gamba
J, et al: Guidelines for the diagnosis, prevention and treatment of
osteoporosis, 2012. Medicina (B Aires). 73:55–74. 2013.(In
Spanish). PubMed/NCBI
|
|
25
|
Himburg HA, Muramoto GG, Daher P, Meadows
SK, Russell JL, Doan P, Chi JT, Salter AB, Lento WE, Reya T, et al:
Pleiotrophin regulates the expansion and regeneration of
hematopoietic stem cells. Nat Med. 16:475–482. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo S, Xie Y, Fan JB, Ji F, Wang S and Fei
H: A-Melanocyte stimulating hormone attenuates
dexamethasone-induced osteoblast damages through activating
melanocortin receptor 4-SphK1 signaling. Biochem Biophys Res
Commun. 469:281–287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu H, Bian W, Liu S and Huang K: Selenium
protects bone marrow stromal cells against hydrogen
peroxide-induced inhibition of osteoblastic differentiation by
suppressing oxidative stress and ERK signaling pathway. Biol Trace
Elem Res. 150:441–450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang Y, Su Y, Wang D, Chen Y, Wu T, Li G,
Sun X and Cui L: Tanshinol attenuates the deleterious effects of
oxidative stress on osteoblastic differentiation via Wnt/FoxO3a
signaling. Oxid Med Cell Longev. 2013:3518952013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liang D, Xiang L, Yang M, Zhang X, Guo B,
Chen Y, Yang L and Cao J: ZnT7 can protect MC3T3-E1 cells from
oxidative stress-induced apoptosis via PI3K/Akt and MAPK/ERK
signaling pathways. Cell Signal. 25:1126–1135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li XM, Yang Q, Li XB, Cheng Q, Zhang K,
Han J, Zhao JN, Liu G and Zhao MG: Estrogen-like neuroprotection of
isopsoralen against spinal cord injury through estrogen receptor
ERα. Metab Brain Dis. 32:259–265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Feng CY, Huang XR, Qi MX, Tang SW, Hu YH,
Chen S and Ke FJ: Mitochondrial proteomic analysis of isopsoralen
protection against oxidative damage in human lens epithelial cells.
Chin J Integr Med. 18:529–533. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Manolagas SC: Birth and death of bone
cells: Basic regulatory mechanisms and implications for the
pathogenesis and treatment of osteoporosis. Endocr Rev. 21:115–137.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Li SF, Wang T, Sun CH, Wang L,
Huang MJ, Chen J, Zheng SW, Wang N, Zhang YJ and Chen TY:
Isopsoralen- mediated suppression of bone marrow adiposity and
attenuation of the adipogenic commitment of bone marrow-derived
mesenchymal stem cells. Int J Mol Med. 39:527–538. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Son Y, Kim S, Chung HT and Pae HO:
Reactive oxygen species in the activation of MAP kinases. Methods
Enzymol. 528:27–48. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Andreyev AY, Kushnareva YE, Murphy AN and
Starkov AA: Mitochondrial ROS metabolism: 10 years later.
Biochemistry (Mosc). 80:517–531. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mailloux RJ: Teaching the fundamentals of
electron transfer reactions in mitochondria and the production and
detection of reactive oxygen species. Redox Biol. 4:381–398. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brand MD: Mitochondrial generation of
superoxide and hydrogen peroxide as the source of mitochondrial
redox signaling. Free Radic Biol Med. 100:14–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Reczek CR and Chandel NS: ROS-dependent
signal transduction. Curr Opin Cell Biol. 33:8–13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kowaltowski AJ, de Souza-Pinto NC,
Castilho RF and Vercesi AE: Mitochondria and reactive oxygen
species. Free Radic Biol Med. 47:333–343. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Herbst RS: Review of epidermal growth
factor receptor biology. Int J Radiat Oncol Biol Phys. 59 (Suppl
2):S21–S26. 2004. View Article : Google Scholar
|
|
41
|
Talasila KM, Soentgerath A, Euskirchen P,
Rosland GV, Wang J, Huszthy PC, Prestegarden L, Skaftnesmo KO,
Sakariassen PØ, Eskilsson E, et al: EGFR wild-type amplification
and activation promote invasion and development of glioblastoma
independent of angiogenesis. Acta Neuropathol. 125:683–698. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li J, He W, Liao B and Yang J:
FFA-ROS-P53-mediated mitochondrial apoptosis contributes to
reduction of osteoblastogenesis and bone mass in type 2 diabetes
mellitus. Sci Rep. 5:127242015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
She C, Zhu LQ, Zhen YF, Wang XD and Dong
QR: Activation of AMPK protects against hydrogen peroxide-induced
osteoblast apoptosis through autophagy induction and NADPH
maintenance: New implications for osteonecrosis treatment? Cell
Signal. 26:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Krishnan V, Bryant HU and Macdougald OA:
Regulation of bone mass by wnt signaling. J Clin Invest.
116:1202–1209. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Valenta T, Hausmann G and Basler K: The
many faces and functions of β-catenin. EMBO J. 31:2714–2736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rossini M, Gatti D and Adami S:
Involvement of WNT/β-catenin signaling in the treatment of
osteoporosis. Calcif Tissue Int. 93:121–132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Baron R and Kneissel M: WNT signaling in
bone homeostasis and disease: From human mutations to treatments.
Nat Med. 19:179–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Baron R, Rawadi G and Roman-Roman S: Wnt
signaling: A key regulator of bone mass. Curr Top Dev Biol.
76:103–127. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang J, Zhang X, Zhang L, Zhou F, van
Dinther M and Ten Dijke P: LRP8 mediates Wnt/beta-catenin signaling
and controls osteoblast differentiation. J Bone Miner Res.
27:2065–2074. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yu HM, Jerchow B, Sheu TJ, Liu B,
Costantini F, Puzas JE, Birchmeier W and Hsu W: The role of Axin2
in calvarial morphogenesis and craniosynostosis. Development.
132:1995–2005. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Gaur T, Lengner CJ, Hovhannisyan H, Bhat
RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS
and Lian JB: Canonical WNT signaling promotes osteogenesis by
directly stimulating Runx2 gene expression. J Biol Chem.
280:33132–33140. 2005. View Article : Google Scholar : PubMed/NCBI
|
